TAFICITA Tablet is a prescription medication used for the treatment and prevention of HIV-1 infection. It is an effective antiretroviral medication prescribed as part of a combination antiretroviral therapy (ART) regimen to suppress HIV viral load and improve immune function. Additionally, it may be used as pre-exposure prophylaxis (PrEP) to prevent HIV infection in individuals at high risk.

Active Ingredients:

TAFICITA contains:

• Tenofovir alafenamide (TAF) – 25 mg
• Emtricitabine (FTC) – 200 mg

These active ingredients belong to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs), which help prevent the replication of HIV in the body.

How Does TAFICITA Tablet Work?

TAFICITA works by inhibiting the action of the reverse transcriptase enzyme, a critical component that HIV uses to replicate its genetic material. This dual-action combination:

• Reduces the HIV viral load in the body.
• Helps maintain and restore immune function.
• Slows the progression of HIV infection and decreases the risk of complications.

When used as PrEP, TAFICITA helps create a protective barrier against HIV infection.

Indications:

• Treatment of HIV-1 infection in adults and adolescents aged 12 years and older, weighing at least 35 kg, as part of a combination ART regimen.
• Pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV in individuals at high risk of exposure.

Key Benefits:

• Effectively suppresses HIV when used as part of combination therapy.
• Offers a reliable option for PrEP to prevent HIV transmission.
• Convenient once-daily dosing improves adherence.
• Lowers the risk of HIV-related complications.

Storage Instructions:

• Store at room temperature (below 30°C) in a dry place.
• Protect from moisture, heat, and direct sunlight.
• Keep out of reach of children.

FAQs:

1. What is TAFICITA Tablet used for?

TAFICITA Tablet is used for:

• Treatment of HIV-1 infection in adults and adolescents aged 12 years and older, as part of a combination antiretroviral therapy (ART) regimen.
• Pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV in individuals at high risk of exposure.

2. What are the active ingredients in TAFICITA Tablet?

TAFICITA contains two active ingredients:

• Tenofovir alafenamide (TAF) – 25 mg
• Emtricitabine (FTC) – 200 mg

Both are nucleoside reverse transcriptase inhibitors (NRTIs) that help block HIV replication.

3. Can TAFICITA Tablet cure HIV?

No, TAFICITA does not cure HIV. It helps manage the infection by suppressing viral replication and improving immune function. Lifelong treatment is necessary to keep the virus under control.

4. How should I take TAFICITA Tablet?

• For HIV treatment: Take 1 tablet daily as prescribed by your doctor.
• For PrEP: Take 1 tablet daily, consistently, to ensure effective protection.
• It can be taken with or without food.

5. What are the common side effects of TAFICITA Tablet?

Common side effects include:

• Nausea
• Headache
• Fatigue
• Dizziness
• Diarrhea

These are usually mild and resolve over time.

6. Is regular monitoring necessary while taking TAFICITA?

Yes, regular medical check-ups are essential to monitor:

• Kidney function (to detect any potential damage).
• Bone health (especially in individuals at risk of osteoporosis).
• HIV status (if taking TAFICITA for PrEP) to confirm HIV-negative status before and during use.

7. Can TAFICITA Tablet interact with other medications?

Yes, TAFICITA may interact with certain medications. Inform your doctor about all medications, supplements, and over-the-counter products you are taking to avoid potential interactions.

8. Is TAFICITA safe to use during pregnancy?

If you are pregnant or planning to become pregnant, consult your doctor before using TAFICITA. Your healthcare provider will assess the risks and benefits and decide on the best course of action.